Conversely, higher levels of α-synuclein over the threshold of cellular clearance capacity, i.e., under conditions similar to PD, trigger the production of oligomeric α-synuclein, leading to a decrease in PAK4 activity (Fig. 1E, left arrow, red). Here, SNCA is linked to Parkinson disease.